Stay updated with breaking news from Toronto Memory Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Cambridge biotech is a pioneer in medicines that rely on RNA interference, a scientific innovation that “silences” disease-causing genes.
Lecanemab was shown to slow cognitive decline in early Alzheimer’s disease and reduce the number of amyloid plaques.
Lecanemab was hailed by headlines as a breakthrough treatment for Alzheimer's. Now, with the death of a third patient, there are concerns about this medication.
Steve McNeil recently skated his 35th marathon to raise awareness and funds for Alzheimer's societies across Canada, while a new drug recently approved by the U.S. Food and Drug Administration
Three-decade hockey referee and mailman Steve McNeil of Etobicoke hits the ice on Saturday for his 35th skating marathon for Alzheimer’s — and he’s asking Torontonians and Canadians to join